Table 1 Characteristics of the study population.
Characteristic | Baseline (n = 384) | Follow-upa | Follow-upa | ||||
|---|---|---|---|---|---|---|---|
Nonfaller (n = 272) | faller (n = 98) | p | Individuals without hospitalization (n = 319) | Individuals with at least one hospitalization (n = 51) | p | ||
Age (years)b | 71.5 (5.8) | 70.6 (5.2) | 73.6 (6.4) | <0.001 | 71.1 (5.7) | 73.4 (5.2) | 0.008 |
Women (%) | 224 (58.3) | 154 (56.6) | 63 (64.3) | 0.186 | 187 (58.6) | 30 (58.8) | 0.978 |
Comorbidities (%) | |||||||
Hypertension | 116 (30.2) | 78 (28.7) | 36 (36.7) | 0.139 | 89 (27.9) | 25 (49.0) | 0.002 |
Coronary heart disease | 36 (9.4) | 21 (7.7) | 14 (14.3) | 0.057 | 29 (9.1) | 6 (11.8) | 0.545 |
Diabetes | 36 (9.4) | 25 (9.2) | 10 (10.2) | 0.769 | 29 (9.1) | 6 (11.8) | 0.545 |
Stroke | 47 (12.2) | 34 (12.5) | 13 (13.3) | 0.845 | 37 (11.6) | 10 (19.6) | 0.111 |
COPD | 32 (8.3) | 21 (7.2) | 11 (11.2) | 0.290 | 27 (8.5) | 5 (9.8) | 0.752 |
Cognitive impairment | 14 (3.6) | 5 (1.8) | 7 (7.1) | 0.011 | 9 (2.8) | 3 (5.9) | 0.252 |
History of falls (%) | 59 (15.4) | 38 (14.0) | 18 (18.4) | 0.298 | 47 (14.7) | 9 (17.6) | 0.590 |
BMI (men, kg/m2)b | 24.1 (3.3) | 24.5 (3.3) | 23.2 (3.2) | 0.035 | 24.3 (3.3) | 24.0 (3.3) | 0.755 |
BMI (women, kg/m2)b | 24.3 (3.3) | 24.4 (3.2) | 23.9 (3.4) | 0.355 | 24.3 (3.3) | 23.7 (2.9) | 0.299 |
GS (men, m/s)b | 0.9 (0.3) | 0.9 (0.3) | 0.9 (0.2) | 0.522 | 0.9 (0.2) | 1.0 (0.3) | 0.365 |
GS (women, m/s)b | 0.9 (0.2) | 0.9 (0.2) | 0.8 (0.2) | <0.001 | 0.9 (0.2) | 0.8 (0.2) | 0.015 |
HS (men, kg)b | 29.4 (8.9) | 29.7 (9.0) | 28.7 (9.1) | 0.578 | 29.8 (9.1) | 27.2 (8.2) | 0.222 |
HS (women, kg)b | 18.3 (5.4) | 19.3 (5.2) | 16.2 (5.2) | <0.001 | 18.8 (5.3) | 16.0 (5.1) | 0.009 |
ASM men, (kg)b | 18.2 (3.0) | 18.5 (2.8) | 17.7 (3.5) | 0.163 | 18.4 (3.0) | 17.6 (2.6) | 0.243 |
ASM (women, kg)b | 12.6 (2.2) | 12.8 (2.2) | 12.0 (2.2) | 0.018 | 12.7 (2.3) | 12.1 (1.9) | 0.182 |
Body fat mass (men, kg)b | 18.1 (6.1) | 18.7 (6.1) | 16.9 (5.9) | 0.121 | 18.2 (6.1) | 18.7 (6.0) | 0.742 |
Body fat mass (women, kg)b | 19.6 (5.3) | 19.7 (5.2) | 19.2 (5.5) | 0.518 | 19.7 (5.2) | 18.4 (5.5) | 0.196 |
EWGSOP-defined sarcopenia (%) | 105 (27.3) | 61 (22.4) | 38 (38.8) | 0.002 | 78 (24.5) | 21 (41.2) | 0.012 |
EWGSOP2-defined sarcopenia (%) | 103 (26.8) | 55 (20.2) | 42 (42.9) | <0.001 | 77 (24.1) | 20 (39.2) | 0.023 |
Modified EWGSOP-defined sarcopenia (%) | 45 (11.7) | 22 (8.1) | 20 (20.4) | 0.001 | 31 (9.7) | 11 (21.6) | 0.013 |
Modified EWGSOP2-defined sarcopenia (%) | 38 (9.9) | 17 (6.3) | 20 (20.4) | <0.001 | 27 (8.5) | 10 (19.6) | 0.014 |
